TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.
Status:
TERMINATED
Trial end date:
2024-07-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficiency of TQB2928 injection combined with Penpulimab in the treatment of patients with advanced malignant tumors.